| Drug Type Small molecule drug | 
| Synonyms YH-40863 | 
| Target | 
| Action agonists | 
| Mechanism GDF15 agonists(Growth/differentiation factor 15 agonists), GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Preclinical | South Korea  | 02 Nov 2023 | |
| Obesity | Preclinical | South Korea  | 02 Nov 2023 | 





